Logos Global Management LP 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-18 5:04 pm Purchase |
2022-03-08 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 265,000 6.900% |
265,000 (New Position) |
Filing |
| 2022-02-15 08:37 am Sale |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 150,000 4.600% |
-33,000 (-18.03%) |
Filing |
| 2021-12-27 5:25 pm Purchase |
2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 183,000 5.600% |
183,000 (New Position) |
Filing |